(Q57273079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Th1/Th2 cytokines reciprocally regulate in vitro pulmonary angiogenesis via CXC chemokine synthesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Akio Matsuda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shuhei Fukuda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kenji Matsumoto

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

20 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory Cell and Molecular Biology

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

168-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

Allergy and allergic diseases. First of two parts

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Airway remodeling and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Increased Airway Vascularity in Newly Diagnosed Asthma Using a High-magnification Bronchovideoscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

CXC chemokines in angiogenesis relevant to chronic fibroproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Evidence of a role of tumor necrosis factor alpha in refractory asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

New molecular targets for the treatment of neutrophilic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Vasculogenesis and angiogenesis depend on the developmental origin in the arterial tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Prevention of exacerbations: how are we doing and can we do better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

Chemokine receptors in chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0162OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2007-0162OC

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709600%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference